http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021267921-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1aed79fe2ca9319783615dace6987540
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84af05cff2b5c3d8cc9a55c342f9a53b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49cc9a107bb8ae46d921e9d82e8f713a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40418d8f16621251dd98c33ac1358890
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9086de8865d378fc3100971259650b35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185d835065507d1c4392abbe5d933cee
publicationDate 2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021267921-A1
titleOfInvention Pharmaceutical composition for preventing or treating allodynia caused by anticancer agents
abstract The present disclosure relates to a composition for preventing, alleviating, or treating allodynia caused by anticancer agents, containing cinnamic acid or a pharmaceutically acceptable salt thereof as an active ingredient. The composition of the present disclosure can prevent, alleviate, or treat allodynia by being administered to a subject scheduled to receive anticancer agents or having received anticancer agents.
priorityDate 2018-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526415

Total number of triples: 32.